Improvement in Left and Right Ventricular Function after Introduction of SGLT2 Inhibitors in Heart Failure Outpatients with Reduced Ejection Fraction.
Gianmarco AlcidiRosanna PuglieseSara IoannoniMatteo RomanoGianpaolo PalmieriErika TabellaMichele CorrealeMatteo Di BiaseNatale Daniele BrunettiMassimo IacovielloPublished in: Clinics and practice (2023)
Our study shows that the addition of SGLT2i to the optimized therapy for HFrEF was associated with a significant improvement in both LV and RV function, thus highlighting a possible mechanism responsible for the benefit obtained with this class of drugs.